Literature DB >> 32243032

B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis.

Camilla Reali1,2, Roberta Magliozzi1,3, Federico Roncaroli1,4,5, Richard Nicholas1, Owain W Howell1,6, Richard Reynolds1.   

Abstract

Increased inflammation in the cerebral meninges is associated with extensive subpial cortical grey matter pathology in the forebrain and a more severe disease course in a substantial proportion of secondary progressive multiple sclerosis (SPMS) cases. It is not known whether this relationship extends to spinal cord pathology. We assessed the contribution of meningeal and parenchymal immune infiltrates to spinal cord pathology in SPMS cases characterized in the presence (F+) or absence (F-) of lymphoid-like structures in the forebrain meninges. Transverse cryosections of cervical, thoracic and lumbar cord of 22 SPMS and five control cases were analyzed for CD20+ B cells, CD4+ and CD8+ T cells, microglia/macrophages (IBA-1+), demyelination (myelin oligodendrocyte glycoprotein+) and axon density (neurofilament-H+). Lymphoid-like structures containing follicular dendritic cell networks and dividing B cells were seen in the spinal meninges of 3 out of 11 F+ SPMS cases. CD4+ and CD20+ cell counts were increased in F+ SPMS compared to F- SPMS and controls, whilst axon loss was greatest in motor and sensory tracts of the F+ SPMS cases (P < 0.01). The density of CD20+ B cells of the spinal leptomeninges correlated with CD4+ T cells and total B and T cells of the meninges; with the density of white matter perivascular CD20+ and CD4+ lymphocytes (P < 0.05); with white matter lesion area (P < 0.05); and the extent of axon loss (P < 0.05) in F+ SPMS cases only. We show that the presence of lymphoid-like structures in the forebrain is associated with a profound spinal cord pathology and local B cell rich meningeal inflammation associates with the extent of cord pathology. Our work supports a principal role for B cells in sustaining inflammation and tissue injury throughout the CNS in the progressive disease stage.
© 2020 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Entities:  

Keywords:  B-cell follicle; axon loss; demyelination; lymphoid-like structures

Year:  2020        PMID: 32243032     DOI: 10.1111/bpa.12841

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  25 in total

Review 1.  T-cell surveillance of the human brain in health and multiple sclerosis.

Authors:  Joost Smolders; Marvin M van Luijn; Cheng-Chih Hsiao; Jörg Hamann
Journal:  Semin Immunopathol       Date:  2022-04-01       Impact factor: 9.623

2.  Immunopathology of the optic nerve in multiple sclerosis.

Authors:  Laura Fernández Blanco; Manuel Marzin; Alida Leistra; Paul van der Valk; Erik Nutma; Sandra Amor
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

3.  Distinct roles of the meningeal layers in CNS autoimmunity.

Authors:  Alexander Flügel; Francesca Odoardi; Arianna Merlini; Michael Haberl; Judith Strauß; Luisa Hildebrand; Nafiye Genc; Jonas Franz; Dmitri Chilov; Kari Alitalo; Cassandra Flügel-Koch; Christine Stadelmann
Journal:  Nat Neurosci       Date:  2022-06-30       Impact factor: 28.771

4.  Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study.

Authors:  Nicola Capasso; Raffaele Palladino; Vincenza Cerbone; Antonio Luca Spiezia; Bianca Covelli; Antonia Fiore; Roberta Lanzillo; Antonio Carotenuto; Maria Petracca; Lucia Stanziola; Giulia Scalia; Vincenzo Brescia Morra; Marcello Moccia
Journal:  J Neurol       Date:  2022-09-01       Impact factor: 6.682

5.  Anti-CD20 Depletes Meningeal B Cells but Does Not Halt the Formation of Meningeal Ectopic Lymphoid Tissue.

Authors:  Rosa Margareta Brand; Verena Friedrich; Jolien Diddens; Monika Pfaller; Francesca Romana de Franchis; Helena Radbruch; Bernhard Hemmer; Katja Steiger; Klaus Lehmann-Horn
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-21

6.  Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.

Authors:  Lynn van Olst; Carla Rodriguez-Mogeda; Carmen Picon; Svenja Kiljan; Rachel E James; Alwin Kamermans; Susanne M A van der Pol; Lydian Knoop; Iliana Michailidou; Evelien Drost; Marc Franssen; Geert J Schenk; Jeroen J G Geurts; Sandra Amor; Nicholas D Mazarakis; Jack van Horssen; Helga E de Vries; Richard Reynolds; Maarten E Witte
Journal:  Acta Neuropathol       Date:  2021-03-29       Impact factor: 17.088

Review 7.  Does Siponimod Exert Direct Effects in the Central Nervous System?

Authors:  Markus Kipp
Journal:  Cells       Date:  2020-07-24       Impact factor: 6.600

Review 8.  An "Outside-In" and "Inside-Out" Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases.

Authors:  B Paul Morgan; Jennifer L Gommerman; Valeria Ramaglia
Journal:  Front Cell Neurosci       Date:  2021-01-07       Impact factor: 5.505

9.  Astrocyte-specific expression of interleukin 23 leads to an aggravated phenotype and enhanced inflammatory response with B cell accumulation in the EAE model.

Authors:  Louisa Nitsch; Simon Petzinna; Julian Zimmermann; Linda Schneider; Marius Krauthausen; Michael T Heneka; Daniel R Getts; Albert Becker; Marcus Müller
Journal:  J Neuroinflammation       Date:  2021-04-27       Impact factor: 8.322

Review 10.  Intrathecal Inflammation in Progressive Multiple Sclerosis.

Authors:  Salvatore Monaco; Richard Nicholas; Richard Reynolds; Roberta Magliozzi
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.